Imatinib mesylate causes growth plate closure in vivo

Leukemia. 2009 Nov;23(11):2155-9. doi: 10.1038/leu.2009.150. Epub 2009 Jul 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / pharmacology
  • Benzamides
  • Child
  • Female
  • Growth Disorders / chemically induced*
  • Growth Plate / drug effects*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Piperazines / adverse effects*
  • Piperazines / pharmacology
  • Pyrimidines / adverse effects*
  • Pyrimidines / pharmacology
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate